Skip to content
SAMDI Tech
Better. Faster. Label-Free.
  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI Affinity Selection Mass Spectrometry (ASMS) Technology
    • Small Molecule Compound Libraries
    • Cell-Based Assays
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us
  • Careers
  • Search

News

  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI Affinity Selection Mass Spectrometry (ASMS) Technology
    • Small Molecule Compound Libraries
    • Cell-Based Assays
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us

Integrating affinity selection mass spectrometry in a drug discovery workflow

High-throughput screening remains one of the most powerful, unbiased approaches in drug discovery for revealing novel small molecule modulators of biochemical…

Four Tips for Selecting a Small Molecule Screening Library

High-throughput screening remains one of the most powerful, unbiased approaches in drug discovery for revealing small molecule modulators of biochemical…

Mass Spectrometry Gaining Momentum for Biochemical Assay Development and Screening

SAMDI Tech, Inc announces publication with Epizyme for characterizing CARM1 methyltransferase

SAMDI Tech Founder Milan Mrksich and Sen. Dick Durbin Discuss Biomedical Research Funding

FEDERAL FUNDING FOR BIOMEDICAL RESEARCH RISES $2 BILLION Sen. Dick Durbin visits Chicago campus to highlight importance of medical research…

SAMDI Tech, Inc announces new publication in Journal of Biomolecular Screening for Assay JBS Vol 20(7) 842-848

Journal of Biomolecular Screening Vol 20(7) 842-848 Discovery of SIRT3 Inhibitors Using SAMDI Mass Spectrometry Kaushal Patel1, John Sherrill1, Milan…

SAMDI Tech and Exquiron Biotech AB – Recent Collaboration on Hit Discovery Project

SAMDI Tech, Inc announces publication with Epizyme for Demethylase Screening

Epizyme Uses SAMDI to Characterize vSET Histone Methyltransferase Activity

SAMDI technology is highlighted in the TECAN Journal

Posts navigation

Older posts
  • Privacy Policy
  • Contact Us

SAMDI Tech, Inc.
3440 South Dearborn Street
Suite 220S
Chicago, IL 60616

Phone: 312.235.3575

© 2023 SAMDI Tech, Inc. All rights reserved.

Connect with us on
  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI Affinity Selection Mass Spectrometry (ASMS) Technology
    • Small Molecule Compound Libraries
    • Cell-Based Assays
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us
  • Careers
  • Search